TY - JOUR
T1 - Thyroid carcinoma metastatic to the skin
T2 - A cutaneous manifestation of a widely disseminated malignancy
AU - Dahl, P. R.
AU - Brodland, D. G.
AU - Goellner, J. R.
AU - Hay, I. D.
PY - 1997
Y1 - 1997
N2 - Background: Cutaneous metastases develop in 2% to 9% of patients with an internal malignancy. Thyroid carcinoma metastatic to the skin is a rare clinical entity. Objective: Our purpose was to study the clinical and pathologic features and outcome in patients with cutaneous metastasis from thyroid carcinoma. Methods: The study included a retrospective analysis of six patients with skin metastases from thyroid carcinoma and a review of the English-language literature since 1964. Results: Including our six patients, 43 patients with skin metastases from thyroid carcinoma have been reported. Papillary carcinoma was the most common (41%), followed by follicular (28%), anaplastic (15%), and medullary carcinomas (15%). The scalp was the most common site of metastasis. For our patients, the average length of survival after diagnosis of cutaneous metastasis was 19 months. Conclusion: Cutaneous metastasis from thyroid carcinoma is rare and occurs in the setting of disseminated neoplastic disease.
AB - Background: Cutaneous metastases develop in 2% to 9% of patients with an internal malignancy. Thyroid carcinoma metastatic to the skin is a rare clinical entity. Objective: Our purpose was to study the clinical and pathologic features and outcome in patients with cutaneous metastasis from thyroid carcinoma. Methods: The study included a retrospective analysis of six patients with skin metastases from thyroid carcinoma and a review of the English-language literature since 1964. Results: Including our six patients, 43 patients with skin metastases from thyroid carcinoma have been reported. Papillary carcinoma was the most common (41%), followed by follicular (28%), anaplastic (15%), and medullary carcinomas (15%). The scalp was the most common site of metastasis. For our patients, the average length of survival after diagnosis of cutaneous metastasis was 19 months. Conclusion: Cutaneous metastasis from thyroid carcinoma is rare and occurs in the setting of disseminated neoplastic disease.
UR - http://www.scopus.com/inward/record.url?scp=0030948479&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030948479&partnerID=8YFLogxK
U2 - 10.1016/S0190-9622(97)70239-1
DO - 10.1016/S0190-9622(97)70239-1
M3 - Article
C2 - 9092737
AN - SCOPUS:0030948479
SN - 0190-9622
VL - 36
SP - 531
EP - 537
JO - Journal of the American Academy of Dermatology
JF - Journal of the American Academy of Dermatology
IS - 4
ER -